[Androgen receptors in breast cancer: Expression, value and therapeutic prospects]. [electronic resource]
- Bulletin du cancer Apr 2017
- 363-369 p. digital
Publication Type: Journal Article; Review
1769-6917
10.1016/j.bulcan.2017.01.005 doi
Abiraterone Acetate--therapeutic use Androgen Antagonists--therapeutic use Antineoplastic Agents--therapeutic use Benzamides Cyclin-Dependent Kinase 4--antagonists & inhibitors Cyclin-Dependent Kinase 6--antagonists & inhibitors Female Humans Ki-67 Antigen--metabolism Lymphatic Metastasis Neoplasm Proteins--metabolism Nitriles Phenylthiohydantoin--analogs & derivatives Prognosis Programmed Cell Death 1 Receptor--antagonists & inhibitors Receptors, Androgen--chemistry Steroid 17-alpha-Hydroxylase--antagonists & inhibitors TOR Serine-Threonine Kinases--antagonists & inhibitors Triple Negative Breast Neoplasms--drug therapy Tumor Burden